BAYER AKTIENGESELLSCHAFT from 19/06/2019 to 19/06/2019 The price-sensitive information presented in other languages is a literal translation of the price-sensitive information stated in Spanish 19/06/2019 16:46 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Not intended for U.S. and UK Media - Regorafenib to be tested in brain cancer patients in multi-arm cooperation trial Register number: 279320